The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies
暂无分享,去创建一个
Sven Christian | D. Scadden | A. Haegebarth | H. Seidel | A. Friberg | R. Lesche | S. Ferrara | M. Bauser | P. Lejeune | L. Evans | A. Janzer | D. Sykes | J. Losman | K. Zimmermann | S. Gradl | A. Eheim | Krzysztof Brzezinka | C. Merz | Hanna Meyer | D. Stoeckigt